I&D assisted and advised the largest Jordanian generics drug-maker largest in the pharmaceuticals sector in its acquisition of the entire issued share capital of one of the largest Egyptian pharmaceuticals company, for $60.5 million. The firm assisted the client in relation to all the aspects related to the acquisition including drafting shareholder and share transfer agreements, conducting due diligence on the target, the implementation of the shares transfer and the amendment of the corporate structure including procuring all the relevant regulatory approvals.
I&D advised the purchasers of the operation of a major pharmaceutical business in Egypt.